Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of PN400 (VIMOVO) in Patients at Risk for NSAID-associated Ulcers
NCT00527904Phase 3Completed
- Sponsor
- Pozen
- Start
- Mar 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naproxen + esomeprazole in osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), sponsored by Pozen. Started Mar 2007; status: completed.
02
Drugs
naproxen + esomeprazole
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00527904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527904.